Wang, Q. (2018). Clofazimine for Treatment of Extensively Drug-Resistant Pulmonary Tuberculosis in China [Clinical Therapeutics]. The American Society for Microbiology (ASM).
Chicago Style (17th ed.) CitationWang, Q. Clofazimine for Treatment of Extensively Drug-Resistant Pulmonary Tuberculosis in China [Clinical Therapeutics]. The American Society for Microbiology (ASM), 2018.
MLA (9th ed.) CitationWang, Q. Clofazimine for Treatment of Extensively Drug-Resistant Pulmonary Tuberculosis in China [Clinical Therapeutics]. The American Society for Microbiology (ASM), 2018.
Warning: These citations may not always be 100% accurate.